ABSI
Absci Corp
Key Financials
Revenue
$4.5M
↓ 20.7%
Operating Income
$-120317000
↓ 10.5%
Net Income
$-115183000
↓ 11.7%
EPS (Diluted)
$-0.84
↑ 10.6%
Total Assets
$216.3M
↑ 1.3%
Total Liabilities
$26.8M
↓ 22.1%
Long-term Debt
$4.0M
↓ 49.6%
Operating Cash Flow
$-92925000.00
↓ 28.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 8/11/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 4 | 8/7/2026 | View on SEC |
| 3 | 8/7/2026 | View on SEC |
| 4 | 7/6/2026 | View on SEC |
| 4 | 6/26/2026 | View on SEC |
| 8-K | 6/24/2026 | View on SEC |
| 424B5 | 6/24/2026 | View on SEC |
| 8-K | 6/24/2026 | View on SEC |
| 4/A | 6/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ABSI |
| Company Name | Absci Corp |
| CIK | 1672688 |
| Sector | Services-Commercial Physical & Biological Research |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 8731 |
| SIC Description | Services-Commercial Physical & Biological Research |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | (360) 949-1041 |